In vivo effects of propranolol on some cellular and humoral immune functions in a group of patients with lepromatous leprosy.
D000917:Antibody Formation / Q000187:drug effects*; D002634:Chemotaxis, Leukocyte / Q000187:drug effects; D003165:Complement System Proteins / Q000032:analysis; D005260:Female; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D007918:Leprosy / Q000188:drug therapy / Q000276:immunology*; D007961:Leukocyte Migration-Inhibitory Factors / Q000096:biosynthesis; D008213:Lymphocyte Activation / Q000187:drug effects; D008214:Lymphocytes / Q000187:drug effects*; D008297:Male; D009504:Neutrophils / Q000187:drug effects*; D011433:Propranolol / Q000494:pharmacology*; D012397:Rosette Formation
D007136:Immunoglobulins; D007961:Leukocyte Migration-Inhibitory Factors; D003165:Complement System Proteins; D011433:Propranolol